These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29021477)

  • 21. Bone and kidney disease: diagnostic and therapeutic implications.
    Jamal SA; West SL; Miller PD
    Curr Rheumatol Rep; 2012 Jun; 14(3):217-23. PubMed ID: 22350608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for patients with CKD and low bone mineral density.
    Ott SM
    Nat Rev Nephrol; 2013 Nov; 9(11):681-92. PubMed ID: 24100401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2020 Jul; 62(1602):105-112. PubMed ID: 32728009
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of osteoporosis in patients with chronic kidney disease.
    Gupta A
    Br J Hosp Med (Lond); 2014 Feb; 75(2):83-9. PubMed ID: 24521803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of drugs for osteoporosis on cardiovascular diseases and effect of cardio vascular drugs on osteoporosis].
    Laroche M; Degboe Y; Blain H; Breuil V; Chapurlat R; Cortet B; Sutter B;
    Presse Med; 2017 Mar; 46(2 Pt 1):159-164. PubMed ID: 28040349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment and prevention of osteoporosis in patients with decreased renal function].
    Vestergaard P; Eiken PA
    Ugeskr Laeger; 2008 Jan; 170(4):227-30. PubMed ID: 18282452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of denosumab compared to bisphosphonates in improving bone strength in postmenopausal osteoporosis: a systematic review.
    Chandran T; Venkatachalam I
    Singapore Med J; 2019 Jul; 60(7):364-378. PubMed ID: 30854568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.
    Yasuda Y; Iwama S; Arima H
    Endocr J; 2019 Mar; 66(3):271-275. PubMed ID: 30713246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.
    Huynh AL; Baker ST; Stewardson AJ; Johnson DF
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1274-1278. PubMed ID: 27255807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
    Hu L; Napoletano A; Provenzano M; Garofalo C; Bini C; Comai G; La Manna G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
    Body JJ; von Moos R; Niepel D; Tombal B
    BMC Urol; 2018 Sep; 18(1):81. PubMed ID: 30236112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Osteoporosis treatment for patients with chronic kidney disease].
    Konishi Y
    Nihon Rinsho; 2015 Oct; 73(10):1723-7. PubMed ID: 26529937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of osteoporosis in renal insufficiency.
    Schipper LG; Fleuren HW; van den Bergh JP; Meinardi JR; Veldman BA; Kramers C
    Clin Rheumatol; 2015 Aug; 34(8):1341-5. PubMed ID: 25630310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study.
    Nishikawa A; Yoshiki F; Taketsuna M; Kajimoto K; Enomoto H
    Clin Interv Aging; 2016; 11():1653-1659. PubMed ID: 27895472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate use in patients undergoing dialysis.
    Vouri SM; Blaszczyk AT
    Consult Pharm; 2013 Nov; 28(11):738-41. PubMed ID: 24217193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteoporosis and chronic kidney disease: review and new therapeutic strategies].
    Sessa C; Galeano D; Alessandrello I; Aprile G; Distefano G; Ficara V; Giglio E; Musumeci S; Pocorobba B; Zuppardo C; Musso S; Granata A
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to manage postmenopausal osteoporosis?
    Body JJ
    Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
    Bird ST; Smith ER; Gelperin K; Jung TH; Thompson A; Kambhampati R; Lyu H; Zhao H; Zhao Y; Zhu Y; Easley O; Niak A; Wernecke M; Chillarige Y; Zemskova M; Kelman JA; Graham DJ
    JAMA; 2024 Feb; 331(6):491-499. PubMed ID: 38241060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.